A new SQL Server 2025 feature lets organizations run vector-based semantic searches on their own data, connecting to local or cloud-hosted AI models without relying on massive general-purpose LLMs.

Microsoft has released the first release candidate for SQL Server 2025, touting AI capabilities and experimental features through PREVIEW_FEATURES.

This article presents analytical, Monte Carlo, and empirical evidence on combining recursive and rolling forecasts when linear predictive models are subject to structural change. Using a ...

Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human ...

Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

Is Recursion Pharma a buy because of Nvidia’s endorsement? Indeed, Nvidia’s bet on Recursion is notable, but despite the stake and collaboration, the name isn’t without its fair share of risks.

According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (RXRX -3.49%) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

Former star SANFL player Luke Ivens emotional reaction to Mitcham Hawks CTE move Junior footy will never look the same again at this popular Adelaide club, and that’s enough to bring a tear to ...